Diagnostic Lab Anatomic Pathology Revenue Mix measures the share of Quest Diagnostics revenue generated by anatomic pathology testing services.
Quest Diagnostics reported 6% of net revenues from anatomic pathology in its 2025 disclosures.
Anatomic pathology was much smaller than gene-based and esoteric testing
Quest reported 38% of net revenues from gene-based and esoteric testing.
The 6% anatomic pathology share was about one-sixth as large, while the two categories together represented 44% of net revenues.
Testing-complexity mix is economically different from customer-channel mix
A high-complexity test can originate from a physician, hospital, or other channel.
Use Diagnostic Lab Gene-Based and Esoteric Testing Revenue Mix to compare testing complexity without conflating it with where the order came from.
Mix does not establish margin by itself
Anatomic pathology has distinct interpretation, staffing, specimen-handling, and reimbursement requirements.
The 6% revenue share therefore should not be read as a direct proxy for contribution margin.
Primary source: Quest Diagnostics 2025 Form 10-K.
Part of the Diagnostic Laboratory Economics
See It in Company Research
These companies are examples of how the concept is reported or discussed in public filings. Definitions can differ by issuer; these links open company research rather than a normalized metric comparison.
- DGXOpen operating-model research →17 of 17 reviewed concepts in Diagnostic Laboratory EconomicsTest complexity and customer-channel mix5 of 5 bridge concepts supportedContinue through this bridge:Diagnostic Lab Gene-Based and Esoteric Testing Revenue MixDiagnostic Lab Hospital Channel Revenue MixDiagnostic Lab Other Information Services Revenue MixDiagnostic Lab Physician Channel Revenue Mix
Continue Research
Continue from the concept into the Grizzly Bulls research surface that best matches the next question. These links are research continuations, not recommendations or required steps.
Compare public companies
Compare anatomic pathology with gene-based and esoteric testing within Quest's testing-complexity mix.
Explore more topics in the Financial Research Encyclopedia.